India is home to some of the leading pharmaceutical companies specializing in cardiac and diabetic care, two critical areas of healthcare that are growing rapidly. With a rise in lifestyle diseases like hypertension, heart ailments, and diabetes, the demand for effective treatments and medications has skyrocketed. Companies like Oidrac Remedies, Sun Pharma, and Lupin are at the forefront of addressing these health challenges by providing innovative, affordable, and quality medicines for cardiac and diabetic patients. Let’s take a closer look at these top cardiac diabetic pharma companies in India and their contributions to the healthcare industry.
Oidrac Remedies, a leading name among the top cardiac diabetic pharma companies in India, sets a high benchmark for delivering superior quality cardiac and diabetic medications. Known for their commitment to innovation, Oidrac Remedies consistently introduces groundbreaking products that cater to the growing needs of patients with heart and diabetic conditions.
Sun Pharmaceutical Industries has made its mark not just in India but globally as a leading pharmaceutical company. Sun Pharma's cardiac care portfolio includes some of the most advanced drugs used to manage cardiovascular diseases. Their wide range of medications covers hypertension, heart failure, and post-heart attack care. As one of the top cardiac diabetic pharma companies in India, Sun Pharma continues to lead in the production of cutting-edge treatments.
Lupin Pharmaceuticals is a well-recognized name in the Indian pharmaceutical industry, particularly for its focus on managing chronic diseases like diabetes and cardiovascular conditions. As one of the top cardiac diabetic pharma companies in India, Lupin offers an extensive range of oral antidiabetics, insulin, and combination therapies.
Glenmark Pharmaceuticals has emerged as a major player in the cardiovascular and diabetes segments. The company is known for producing high-quality, affordable drugs that meet international standards. As one of the top cardiac diabetic pharma companies in India, Glenmark is committed to improving access to cardiac and diabetic care across the nation.
Zydus Cadila, under Cadila Healthcare, has made significant strides in both the cardiac and diabetic care sectors. Their innovative approach and deep-rooted commitment to improving patient outcomes have made them a key player among the top cardiac diabetic pharma companies in India.
India is home to numerous pharmaceutical companies that are making remarkable strides in cardiac and diabetic care. While Oidrac Remedies remains at the forefront with its extensive product range and robust franchise support system, companies like Sun Pharmaceutical Industries, Lupin Pharmaceuticals, Glenmark Pharmaceuticals, and Cadila Healthcare are also vital players in this space. These top cardiac diabetic pharma companies in India not only contribute to improving healthcare outcomes but also help in making quality medications affordable and accessible to all sections of society. The combined efforts of these top cardiac diabetic pharma companies in India play a crucial role in addressing the growing prevalence of cardiovascular and diabetic disorders, offering patients hope for better management and treatment of these chronic conditions.
Oidrac Remedies excels with its comprehensive product range, quality manufacturing, affordable pricing, and robust franchise opportunities, providing high-quality cardiac and diabetic medications at competitive prices.
Glenmark Pharmaceuticals is known for providing affordable diabetic medications without compromising on quality, ensuring better access to life-saving treatments.
Lupin’s top cardiac care products include Glimepiride, Metformin, and Atorvastatin, which are effective in managing cardiovascular risk and diabetes-related complications.
Sun Pharmaceutical Industries has a strong global presence and focuses on bringing innovative and advanced treatments for heart and diabetes care, with products like Amlodipine and Clopidogrel leading the way.
Zydus Cadila focuses on providing high-quality diabetic medications like Insulin Glargine and Metformin, alongside patient education initiatives to raise awareness about diabetes management.
S.NO | PRODUCT NAME | Composition | Packing |
---|---|---|---|
1 | TALPIYES™-40 | Telmisartan 40 mg | 10X15 |
2 | TALPIYES™-40 H | Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg | 10X15 |
3 | TALPIYES™-AM | Telmisartan 40 mg + Amlodipine 5 mg | 10X15 |
4 | OID-NG 2.6 | Nitroglycerin 2.6 mg | 30 Tablet |
5 | OID-NG 6.4 | Nitroglycerin 6.4 mg | 30 Tablet |
6 | OIDCLICK-10 | Cilnidipine 10 mg | 10X10 |
7 | OIDCLICK--Т 10/40 | Telmisartan 40 mg & Cilnidipine 10 mg | 10X10 |
8 | METPYUS-25 | Metoprolol Succinate (ER) 25 mg | 10X10 |
9 | METPYUS-50 | Metoprolol Succinate (ER) 50 mg | 10X10 |
10 | METPYUS-AM 50/5 | Metoprolol Succinate (PR) 50 mg + Amlodipine 5 mg | 10X10 |
11 | RACOLME-20 | Olmesartan Medoxomil 20 mg | 10X10 |
12 | RACOLME-H 20/125 | Olmesartan Medoxomil 20 mg + Hydrochlorothiazide 12.5 mg | 10X10 |
13 | RUSOCUR™-10 | Rosuvastatin 10 mg | 10X10 |
14 | RUSOCUR™-20 | Rosuvastatin 20 mg | 10X10 |
15 | RUSOCUR™-20 GOLD | Rosuvastatin 20 mg + Aspirin 75 mg + Clopidogrel 75 mg | 10X10 |
16 | RUSOCUR-10 GOLD | Rosuvastatin 10 mg + Aspirin 75 mg + Clopidogrel 75 mg | 10X10 |
17 | THYADE-25 | Thyroxine Sodium IP 25 mcg | 100 Tab |
18 | THYADE-50 | Thyroxine Sodium IP 50 mcg | 100 Tab |
19 | THYADE-75 | Thyroxine Sodium IP 75 mcg | 100 Tab |
20 | THYADE-100 | Thyroxine Sodium IP 100 mcg | 100 Tab |
21 | OIDSAR-50 | Losartan Potassium 50 mg | 10X10 |